Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
35,525,549
-
Share change
-
-353,937
-
Total reported value
-
$3,104,620,640
-
Put/Call ratio
-
102%
-
Price per share
-
$87.40
-
Number of holders
-
152
-
Value change
-
+$54,058,353
-
Number of buys
-
93
-
Number of sells
-
74
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2017
As of 30 Jun 2017,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
152 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,525,549 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Partner Fund Management, L.P., and MILLENNIUM MANAGEMENT LLC.
This page lists
152
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.